Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1079 | 9902 | 38.0 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
1079 | 2 | BETA3 ADRENOCEPTOR//ADENYLYL CYCLASE//G PROTEIN | 9902 |
756 | 1 | G PROTEIN//TRANSDUCIN//MED COMM NEUROSCI | 3102 |
6581 | 1 | BETA ADRENOCEPTOR//BETA ADRENERGIC RECEPTOR SUBTYPES//BETA ADRENERGIC RECEPTOR | 1467 |
7382 | 1 | JOURNAL OF CYCLIC NUCLEOTIDE RESEARCH//JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH//JOURNAL OF RECEPTOR RESEARCH | 1373 |
8730 | 1 | BETA3 ADRENOCEPTOR//BRL 37344//ATYPICAL BETA ADRENOCEPTORS | 1224 |
10163 | 1 | ADENYLYL CYCLASE//ABT PHARMAZEUT BIOCHEM//ADENYLYL CYCLASE ISOFORMS | 1086 |
14153 | 1 | COLEUS FORSKOHLII//FORSKOLIN//NKH477 | 788 |
19012 | 1 | CAROTID GLOMUS//CATECHOLAMINERGIC LESIONS//NK2 TACHYKININ RECEPTOR | 526 |
23729 | 1 | MEMBRANE LIPID THERAPY//MOL CELLULAR BIOMED//MOL CELL BIOMED | 336 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BETA3 ADRENOCEPTOR | authKW | 431128 | 2% | 70% | 199 |
2 | ADENYLYL CYCLASE | authKW | 380174 | 5% | 26% | 477 |
3 | G PROTEIN | authKW | 193785 | 6% | 11% | 593 |
4 | BETA ADRENOCEPTOR | authKW | 155047 | 3% | 20% | 254 |
5 | BRL 37344 | authKW | 141992 | 1% | 79% | 58 |
6 | ATYPICAL BETA ADRENOCEPTORS | authKW | 114027 | 0% | 100% | 37 |
7 | COLEUS FORSKOHLII | authKW | 93197 | 0% | 69% | 44 |
8 | BETA ADRENERGIC RECEPTOR | authKW | 79064 | 2% | 14% | 180 |
9 | CGP 12177 | authKW | 71843 | 0% | 53% | 44 |
10 | BETA 3 ADRENERGIC RECEPTOR | authKW | 71320 | 1% | 35% | 66 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 17962 | 26% | 0% | 2609 |
2 | Biochemistry & Molecular Biology | 15596 | 35% | 0% | 3464 |
3 | Cardiac & Cardiovascular System | 4224 | 9% | 0% | 920 |
4 | Cell Biology | 3583 | 12% | 0% | 1145 |
5 | Biophysics | 2589 | 7% | 0% | 683 |
6 | Physiology | 2385 | 6% | 0% | 624 |
7 | Peripheral Vascular Diseases | 1610 | 4% | 0% | 444 |
8 | Medicine, Research & Experimental | 576 | 4% | 0% | 402 |
9 | Geriatrics & Gerontology | 509 | 1% | 0% | 148 |
10 | Endocrinology & Metabolism | 370 | 4% | 0% | 363 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT PHARMAZEUT BIOCHEM | 24646 | 0% | 67% | 12 |
2 | MOL CELLULAR BIOMED | 22007 | 0% | 71% | 10 |
3 | MOL CELL BIOMED | 20019 | 0% | 50% | 13 |
4 | MED COMM NEUROSCI | 12327 | 0% | 100% | 4 |
5 | MOL GR H MOL MODELING | 9245 | 0% | 100% | 3 |
6 | PHARMACOL | 8497 | 7% | 0% | 708 |
7 | MOL PHARMACOL GRP | 8033 | 0% | 8% | 32 |
8 | PHYSIOPATHOL PHARMACOL CELLULAI MOL | 7322 | 0% | 24% | 10 |
9 | RED CROSS HOSP GUANGZHOU CITY | 7041 | 0% | 57% | 4 |
10 | UNIT RADIOPHARM | 6933 | 0% | 75% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 39338 | 0% | 33% | 39 |
2 | MOLECULAR PHARMACOLOGY | 25267 | 3% | 3% | 285 |
3 | JOURNAL OF CYCLIC NUCLEOTIDE RESEARCH | 22856 | 0% | 29% | 26 |
4 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 19012 | 0% | 21% | 29 |
5 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 16212 | 2% | 3% | 180 |
6 | JOURNAL OF BIOLOGICAL CHEMISTRY | 15182 | 9% | 1% | 894 |
7 | JOURNAL OF RECEPTOR RESEARCH | 14248 | 1% | 9% | 52 |
8 | ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH | 8117 | 0% | 20% | 13 |
9 | CELLULAR SIGNALLING | 7923 | 1% | 2% | 107 |
10 | BRITISH JOURNAL OF PHARMACOLOGY | 7768 | 2% | 1% | 216 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BETA3 ADRENOCEPTOR | 431128 | 2% | 70% | 199 | Search BETA3+ADRENOCEPTOR | Search BETA3+ADRENOCEPTOR |
2 | ADENYLYL CYCLASE | 380174 | 5% | 26% | 477 | Search ADENYLYL+CYCLASE | Search ADENYLYL+CYCLASE |
3 | G PROTEIN | 193785 | 6% | 11% | 593 | Search G+PROTEIN | Search G+PROTEIN |
4 | BETA ADRENOCEPTOR | 155047 | 3% | 20% | 254 | Search BETA+ADRENOCEPTOR | Search BETA+ADRENOCEPTOR |
5 | BRL 37344 | 141992 | 1% | 79% | 58 | Search BRL+37344 | Search BRL+37344 |
6 | ATYPICAL BETA ADRENOCEPTORS | 114027 | 0% | 100% | 37 | Search ATYPICAL+BETA+ADRENOCEPTORS | Search ATYPICAL+BETA+ADRENOCEPTORS |
7 | COLEUS FORSKOHLII | 93197 | 0% | 69% | 44 | Search COLEUS+FORSKOHLII | Search COLEUS+FORSKOHLII |
8 | BETA ADRENERGIC RECEPTOR | 79064 | 2% | 14% | 180 | Search BETA+ADRENERGIC+RECEPTOR | Search BETA+ADRENERGIC+RECEPTOR |
9 | CGP 12177 | 71843 | 0% | 53% | 44 | Search CGP+12177 | Search CGP+12177 |
10 | BETA 3 ADRENERGIC RECEPTOR | 71320 | 1% | 35% | 66 | Search BETA+3+ADRENERGIC+RECEPTOR | Search BETA+3+ADRENERGIC+RECEPTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PENNINGTON, SR , (1994) GTP-BINDING PROTEINS - HETEROTRIMERIC G-PROTEINS.PROTEIN PROFILE. VOL. 1. ISSUE 3. P. 169 -342 | 1012 | 52% | 27 |
2 | PENNINGTON, SR , (1995) GTP-BINDING PROTEINS .1. HETEROTRIMERIC G PROTEINS.PROTEIN PROFILE. VOL. 2. ISSUE 3. P. 167 -+ | 1097 | 48% | 6 |
3 | GILMAN, AG , (1987) G-PROTEINS - TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 56. ISSUE . P. 615-649 | 119 | 73% | 5759 |
4 | SADANA, R , DESSAUER, CW , (2009) PHYSIOLOGICAL ROLES FOR G PROTEIN-REGULATED ADENYLYL CYCLASE ISOFORMS: INSIGHTS FROM KNOCKOUT AND OVEREXPRESSION STUDIES.NEUROSIGNALS. VOL. 17. ISSUE 1. P. 5-22 | 133 | 69% | 107 |
5 | URSINO, MG , VASINA, V , RASCHI, E , CREMA, F , DE PONTI, F , (2009) THE BETA(3)-ADRENOCEPTOR AS A THERAPEUTIC TARGET: CURRENT PERSPECTIVES.PHARMACOLOGICAL RESEARCH. VOL. 59. ISSUE 4. P. 221 -234 | 126 | 79% | 67 |
6 | VRYDAG, W , MICHEL, MC , (2007) TOOLS TO STUDY BETA(3)-ADRENOCEPTORS.NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. VOL. 374. ISSUE 5-6. P. 385-398 | 104 | 87% | 40 |
7 | BIRNBAUMER, L , ABRAMOWITZ, J , BROWN, AM , (1990) RECEPTOR-EFFECTOR COUPLING BY G-PROTEINS.BIOCHIMICA ET BIOPHYSICA ACTA. VOL. 1031. ISSUE 2. P. 163-224 | 169 | 46% | 1080 |
8 | BRODDE, OE , (1991) BETA-1-ADRENOCEPTORS AND BETA-2-ADRENOCEPTORS IN THE HUMAN HEART - PROPERTIES, FUNCTION, AND ALTERATIONS IN CHRONIC HEART-FAILURE.PHARMACOLOGICAL REVIEWS. VOL. 43. ISSUE 2. P. 203-242 | 179 | 56% | 433 |
9 | MICHEL, MC , KORSTANJE, C , (2016) BETA(3)-ADRENOCEPTOR AGONISTS FOR OVERACTIVE BLADDER SYNDROME: ROLE OF TRANSLATIONAL PHARMACOLOGY IN A REPOSITIONING CLINICAL DRUG DEVELOPMENT PROJECT.PHARMACOLOGY & THERAPEUTICS. VOL. 159. ISSUE . P. 66 -82 | 123 | 53% | 1 |
10 | WANG, X , DHALLA, NS , (2000) MODIFICATION OF BETA-ADRENOCEPTOR SIGNAL TRANSDUCTION PATHWAY BY GENETIC MANIPULATION AND HEART FAILURE.MOLECULAR AND CELLULAR BIOCHEMISTRY. VOL. 214. ISSUE 1-2. P. 131 -155 | 152 | 67% | 23 |
Classes with closest relation at Level 2 |